Gabelli Funds’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.27M | Sell |
16,329
-21
| -0.1% | -$9.35K | 0.05% | 389 |
|
|
2025
Q1 | $7.93M | Sell |
16,350
-1,324
| -7% | -$642K | 0.06% | 343 |
|
|
2024
Q4 | $7.12M | Buy |
17,674
+275
| +2% | +$111K | 0.05% | 362 |
|
|
2024
Q3 | $8.09M | Sell |
17,399
-4,693
| -21% | -$2.18M | 0.06% | 345 |
|
|
2024
Q2 | $10.4M | Sell |
22,092
-217
| -1% | -$102K | 0.08% | 303 |
|
|
2024
Q1 | $9.33M | Sell |
22,309
-480
| -2% | -$201K | 0.07% | 321 |
|
|
2023
Q4 | $9.27M | Buy |
22,789
+105
| +0.5% | +$42.7K | 0.07% | 310 |
|
|
2023
Q3 | $7.89M | Sell |
22,684
-465
| -2% | -$162K | 0.06% | 340 |
|
|
2023
Q2 | $8.15M | Sell |
23,149
-1,492
| -6% | -$525K | 0.06% | 346 |
|
|
2023
Q1 | $7.76M | Buy |
24,641
+1,477
| +6% | +$465K | 0.06% | 364 |
|
|
2022
Q4 | $6.69M | Buy |
23,164
+1,158
| +5% | +$334K | 0.05% | 391 |
|
|
2022
Q3 | $6.37M | Sell |
22,006
-4,095
| -16% | -$1.19M | 0.05% | 396 |
|
|
2022
Q2 | $7.36M | Sell |
26,101
-11,861
| -31% | -$3.34M | 0.06% | 383 |
|
|
2022
Q1 | $9.91M | Buy |
37,962
+6,666
| +21% | +$1.74M | 0.07% | 347 |
|
|
2021
Q4 | $6.87M | Buy |
31,296
+6,000
| +24% | +$1.32M | 0.04% | 433 |
|
|
2021
Q3 | $4.59M | Buy |
25,296
+15,421
| +156% | +$2.8M | 0.03% | 528 |
|
|
2021
Q2 | $1.99M | Buy |
+9,875
| New | +$1.99M | 0.01% | 755 |
|